- Home
- MTC vs KRRO Comparison
MTC vs KRRO Comparison
Compare MTC & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MTC | KRRO |
|---|---|---|
| Founded | 2015 | 2014 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.8M | 58.6M |
| IPO Year | 2019 | 2019 |
Fundamental Metrics
Financial Performance| Metric | MTC | KRRO |
|---|---|---|
| Price | $3.15 | $8.91 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $74.17 |
| AVG Volume (30 Days) | 52.9K | ★ 183.5K |
| Earning Date | 04-10-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $2,675,833.00 | ★ $7,371,000.00 |
| Revenue This Year | N/A | $144.83 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 114.77 | N/A |
| 52 Week Low | $0.25 | $5.20 |
| 52 Week High | $3.89 | $55.89 |
Technical Indicators
Market Signals| Indicator | MTC | KRRO |
|---|---|---|
| Relative Strength Index (RSI) | 53.78 | 44.92 |
| Support Level | $2.54 | $8.62 |
| Resistance Level | $3.04 | $9.59 |
| Average True Range (ATR) | 0.29 | 0.51 |
| MACD | -0.07 | 0.49 |
| Stochastic Oscillator | 50.21 | 65.50 |
Price Performance
Historical ComparisonAbout MTC MMTec Inc.
MMTEC Inc provides Internet-based technology services and solutions to the Chinese language speaking hedge funds, mutual funds, registered investment advisors, proprietary trading groups, and brokerage firms engaging in securities market transactions and settlements globally. It offers complete suite trading solutions, including services such as fund establishment, issuance, custody, transaction, and settlement. The Company currently has two operating segments, Gujia, MM Future, HC Securities, and MM Global. It generates maximum revenue from the Gujia segment. Gujia segment provides market data services and investor relations management services to customers in China.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.